Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


Strengths

● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 57.76 EUR in weekly data.

● The close medium term support offers good timing for purchasing the stock.

● The prospective high growth for the next fiscal years is among the main assets of the company

● Historically, the company has been releasing figures that are above expectations.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.25 for the 2016 fiscal year.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The stock is in a well-established, long-term rising trend above the technical support level at 57.76 EUR


Weaknesses

● The company sustains low margins.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 337.87 times its estimated earnings per share for the ongoing year.

● The company is not the most generous with respect to shareholders' compensation.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.